# Stratified Causal Inference for Intensive Care Unit Risk Prediction: Informatics-Based Modeling of Anesthetic Drug Combinations

**Authors:** Junqi Cui, Weijia Li, Enoch Chi Ngai Lim, Xiaoqin Wu, Chi Eung Danforn Lim

PMC · DOI: 10.2196/80294 · JMIR Formative Research · 2026-02-25

## TL;DR

This paper introduces a machine learning model to identify optimal anesthetic drug combinations and predict ICU admission risk after surgery.

## Contribution

A novel causal machine learning framework for precision anesthesia dosing and ICU risk prediction using stratified analysis of electronic health records.

## Key findings

- High-risk fentanyl-propofol combinations increased ICU admission risk by 36%.
- Six patient subgroups showed distinct dose-response patterns, with vulnerable populations at higher risk.
- Optimal propofol and fentanyl dose ranges were identified to minimize ICU admission risk.

## Abstract

Postoperative intensive care unit (ICU) admission affects 15% to 20% of surgical patients and represents a major source of morbidity and health care costs. Current anesthetic dosing relies on empirical guidelines rather than individualized risk assessment. We developed a counterfactual dose-response model to identify optimal fentanyl-propofol combinations.

This study aimed to develop and evaluate a stratified, causal machine learning framework using electronic health record data to identify optimal fentanyl-propofol dose combinations and predict postoperative ICU admission risk, enabling precision anesthesia and individualized clinical decision support.

We analyzed perioperative electronic health records of 67,134 surgical procedures from UC Irvine Medical Center (2017‐2022). A hierarchical learning framework was used to estimate causal effects while controlling for confounding variables. A total of 6 dose-sensitive subgroups were identified through stratified analysis. The primary end point was postoperative ICU admission.

High-risk combinations (fentanyl >5 mcg/kg with propofol <1 mg/kg) increased ICU admissions’ absolute risk difference by 36% (absolute risk increase; 95% CI 0.351-0.509; P<.001). A total of 6 patient subgroups demonstrated distinct dose-response patterns, with populations considered vulnerable (high glucose, elevated creatinine) showing elevated risk even at standard doses. The optimal dose range for decision-making was determined to be 1.25 to 4.25 mg/kg for propofol and 3.5 to 4.0 mcg/kg for fentanyl.

Fentanyl-propofol combinations exhibit complex, nonlinear dose-response relationships with ICU admission risk. High-dose combinations markedly increase risk through synergistic effects, while specific patient subgroups require enhanced monitoring even at standard doses. These findings support the development of individualized dosing algorithms and risk assessment tools that could inform future decision support tools aimed at reducing postoperative ICU use, although their predictive performance and clinical impact would require external validation.

## Linked entities

- **Chemicals:** fentanyl (PubChem CID 3345), propofol (PubChem CID 4943)

## Full-text entities

- **Genes:** SHROOM4 (shroom family member 4) [NCBI Gene 57477] {aka MRXSSDS, SHAP, shrm4}
- **Diseases:** hyperglycemia (MESH:D006943), hypocalcemia (MESH:D006996), hyperlipidemia (MESH:D006949), cardiovascular and respiratory depression (MESH:D012140), pain (MESH:D010146), hyperglycemic (MESH:D006944), hypertension (MESH:D006973), CDT (MESH:D020195), thrombocytopenia (MESH:D013921), diabetes mellitus (MESH:D003920), MOVER (MESH:D002318), chronic kidney disease (MESH:D051436), cardiopulmonary depression (MESH:D006323), bleeding (MESH:D006470), respiratory depressant (MESH:D012131), tuberculosis (MESH:D014376), Postoperative (MESH:D019106), chest wall rigidity (MESH:D009127), hypotension (MESH:D007022)
- **Chemicals:** oxygen (MESH:D010100), potassium (MESH:D011188), Fentanyl (MESH:D005283), Propofol (MESH:D015742), calcium (MESH:D002118), blood glucose (MESH:D001786), creatinine (MESH:D003404), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935416/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935416/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935416/full.md

---
Source: https://tomesphere.com/paper/PMC12935416